RecruitingInterventional

Advancing Lung Cancer Screening One Text at a Time

NCT ID: NCT07227480Sponsor: University of RochesterLast updated: 2026-02-19

Summary

The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.

Detailed description

We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.

Arms & interventions

BehavioralText messaging program
A text messaging program designed to promote lung cancer screening
BehavioralEducational material
A mailed educational material along with a flyer for the lung cancer screening program

Outcome measures

Primary

Percent of Participants Who Undergo Lung Cancer Screening
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Time frame: Month 3

Eligibility criteria

Sex: AllAge: 50 Years to 80 YearsHealthy volunteers: No

Inclusion Criteria: * 50 to 80 years old * have not completed their annual screening for lung cancer * have a 20 pack-year smoking history * currently smoke or have quit within the past 15 years * speak English and/or Spanish * have a functioning cellphone number with unlimited text messaging capacity * be willing to complete a baseline and a follow-up (at Month 3) survey Exclusion Criteria: * being up-to-date on their annual lung cancer screening

Study locations (1)

University of Rochester Medical Center

Rochester, New York, 14642

Recruiting

Francisco Cartujano, MD · Contact

585-353-0035 francisco_cartujano@urmc.rochester.edu

Francisco Cartujano, MD · Principal Investigator